Author

Mark W. Widder

Walter Reed Army Institute of ResearchORCID 0000-0002-6301-1028Unclaimed ORCID profile · follow to get notified of new preprints

Biology Disciplines

Click to filter author papers

Pharmacology & Toxicology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Research Focus:drug response / drug discovery· 1 Approach:experimental assay· 1 Organism:zebrafish· 1

Frequent Co-Authors

Ashley Moore· 1 shared Blair C. R. DancyiD· 1 shared Chance M CarbaughiD· 1 shared Charlotte Anne Lanteri· 1 shared Kevin S. AkersiD· 1 shared Linda M. Brennan· 1 shared Michael S. MadejczykiD· 1 shared Mónica Miró Martín· 1 shared

Activity by Year

2024-2024 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 45 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperPharmacology & Toxicology

Ashley Moore

Mutual co-authors in cluster

Author profile →

1 paper

Recent·Most cited

Identification of potential sepsis therapeutic drugs using a zebrafish rapid screening approach

Mark W. Widder, Chance M Carbaugh, William H. van der Schalie, Ronald Miller, Linda M. Brennan, Ashley Moore, Robert F. Campbell, Kevin S. Akers, Roseanne A. Ressner, Mónica Miró Martín, Michael S. Madejczyk, Blair C. R. Dancy, Patricia J. Lee, Charlotte Anne Lanteri

This study identifies three FDA-approved drugs that rescue zebrafish from sepsis-like endotoxicity with no neurobehavioral side effects.

Life · Dec 20, 2024Peer-reviewedPharmacology & Toxicology